A detailed history of Rhenman & Partners Asset Management Ab transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 45,270 shares of TMDX stock, worth $2.89 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
45,270
Previous 13,500 235.33%
Holding current value
$2.89 Million
Previous $2.03 Million 249.58%
% of portfolio
0.59%
Previous 0.2%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$135.68 - $176.11 $4.31 Million - $5.6 Million
31,770 Added 235.33%
45,270 $7.11 Million
Q2 2024

Aug 13, 2024

BUY
$72.62 - $150.62 $980,370 - $2.03 Million
13,500 New
13,500 $2.03 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.03B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.